Synairgen (LSE: SNG), a respiratory and drug discovery-focused venture in the UK has received expedited approval rom the UK-based Medicines and Healthcare Products Regulatory Agency (MHRA) and Health Research Authority (HRA) to conduct a trial of SNG001 (inhaled...